Jin Medical International Ltd. (ZJYL)
NASDAQ: ZJYL · Real-Time Price · USD
0.1428
+0.0008 (0.56%)
At close: Mar 3, 2026, 4:00 PM EST
0.1456
+0.0028 (1.96%)
After-hours: Mar 3, 2026, 4:15 PM EST

Jin Medical International Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Net Income
1.193.682.882.712.63
Depreciation & Amortization
0.350.350.230.360.35
Loss (Gain) From Sale of Assets
0.040-0.01-0.01
Provision & Write-off of Bad Debts
0.11-0.050.120.03-0.11
Other Operating Activities
0.12-0.260.09-0.09-0
Change in Accounts Receivable
2.27-3.91-0.380.333.08
Change in Inventory
0.170.081.56-0.50.48
Change in Accounts Payable
0.29-0.5-0.65-0.81-0.37
Change in Unearned Revenue
-0.17-0.060.02-0.760.65
Change in Income Taxes
-0.790.820.030.16-0.1
Change in Other Net Operating Assets
-0.67-1.35-0.780.15-0.78
Operating Cash Flow
2.9-1.213.111.585.84
Operating Cash Flow Growth
--96.53%-72.95%133.44%
Capital Expenditures
-6.63-0.14-0.11-0.04-0.04
Sale of Property, Plant & Equipment
000.01--
Cash Acquisitions
-0.5----
Sale (Purchase) of Intangibles
--0.98---
Investment in Securities
-3.66-8.39-7.63-0.45-0.81
Other Investing Activities
---0.36-0.22
Investing Cash Flow
-10.79-9.51-7.73-0.12-1.07
Short-Term Debt Issued
19.0216.95.670.120.77
Total Debt Issued
19.0216.95.670.120.77
Short-Term Debt Repaid
-11.57-5.56-5.89--3.64
Total Debt Repaid
-11.57-5.56-5.89--3.64
Net Debt Issued (Repaid)
7.4611.34-0.210.12-2.87
Issuance of Common Stock
-0.318.34--
Other Financing Activities
-0.1--1.21--
Financing Cash Flow
7.3511.656.910.12-2.87
Foreign Exchange Rate Adjustments
-0.140.27-0.15-0.460.1
Net Cash Flow
-0.671.212.141.122.01
Free Cash Flow
-3.73-1.352.991.545.8
Free Cash Flow Growth
--94.25%-73.44%145.69%
Free Cash Flow Margin
-18.01%-5.75%15.10%8.03%27.93%
Free Cash Flow Per Share
-0.02-0.010.020.010.04
Cash Interest Paid
0.410.240.01-0.07
Cash Income Tax Paid
0.560.210.140.010.3
Levered Free Cash Flow
-5.110.69-1.571.344.07
Unlevered Free Cash Flow
-5.110.69-1.571.344.08
Change in Working Capital
1.1-4.92-0.2-1.432.96
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q